Friday, November 21, 2014 8:26:39 AM
Sylios and GCC announced on August 15, 2014 an Agreement with Artemis Dispensing Technologies (“Artemis”) which licenses “particular technologies with respect to Cannabis related dispensary units… and to the utilization of said technologies, in the development, marketing and sale of said units.” The dispensing product is expected to be completed and launched during the fourth quarter of 2014.
Currently, recreational marijuana is available in both Colorado and Washington. State law in each of these jurisdictions requires testing – which explains Greenscape Laboratories, Inc.’s involvement.
Greenscape Laboratories, Inc. will provide the testing services required for retail sales through the automated dispensing kiosks. Greenscape believes this vertical integration will provide it with additional revenue, i.e., both from the testing services and from its investment in Sylios Corp.
Integral to the Agreement between Sylios and Greenscape, are cross-consulting agreements. The parties will be compensated in stock for these services, resulting in an investment in Sylios by Greenscape and vice versa.
Don't quote history to me.... there's no future in it.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM